EcoDrugPlus

Natriuretic Peptide Receptor 3

Ensembl ID : ENSORLG00000017232
Gene Symbol: NPR3
3 Cross references
211 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 1

Ensembl ID : ENSORLG00000005182
Gene Symbol: LOC101171596
4 Cross references
196 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-2

Ensembl ID : ENSORLG00000000865
Gene Symbol: LOC101158195
4 Cross references
193 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSORLG00000018774
Gene Symbol: LOC101168927
3 Cross references
183 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7-Like

Ensembl ID : ENSORLG00000030549
Gene Symbol: LOC101166204
3 Cross references
205 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSORLG00000030510
Gene Symbol: NPY2R
1 Cross references
184 Possible Orthologues:

Neuropeptide Y Receptor Y2, Like

Ensembl ID : ENSORLG00000002440
Gene Symbol: NPY2RL
4 Cross references
176 Possible Orthologues:

Neuropeptide Y Receptor Type 1-Like

Ensembl ID : ENSORLG00000009534
Gene Symbol: LOC101168234
4 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSORLG00000002419
Gene Symbol: NTSR1
4 Cross references
202 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSORLG00000005227
Gene Symbol: NTRK2
4 Cross references
208 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSORLG00000014606
Gene Symbol: NTRK3
4 Cross references
192 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 1

Ensembl ID : ENSORLG00000023848
Gene Symbol: NTRK1
4 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).